Evidence map›Paper›PMID 39309878›Full record

ReviewHeliyon2024

LINC01094: A key long non-coding RNA in the regulation of cancer progression and therapeutic targets.

Qiang Yi, Gangfeng Zhu, Weijian Zhu, Jiaqi Wang, Xinting Ouyang, Kuan Yang, Yu Fan, Jinghua Zhong

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiang YiThe First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi Province, 341000, China.
Gangfeng ZhuThe First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi Province, 341000, China.
Weijian ZhuThe First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi Province, 341000, China.
Jiaqi WangThe First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi Province, 341000, China.
Xinting OuyangThe First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi Province, 341000, China.
Kuan YangThe First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi Province, 341000, China.
Yu FanThe First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi Province, 341000, China.
Jinghua ZhongDepartment of Oncology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi Province, 341000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LINC01094 is a long non-coding RNA that plays a crucial role in cancer progression by modulating key signaling pathways, such as PI3K/AKT, Wnt/β-catenin and TGF-β Signaling Pathway Feedback Loop. In this review we summarize the recent research on the functional mechanisms of LINC01094 in various cancers, including its impact on tumor growth, metastasis, and resistance to therapy. We also discuss the therapeutic potential of targeting LINC01094 and highlight the current strategies and challenges in this area. Perspectives on future development of LINC01094-based therapies are also provided.

Indexed as

BiologicalClinical therapiesLINC01094lncRNAMalignant cancers

Identifiers

PMID39309878
PMCPMC11415682

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.